ReviewFrontiers in oncology2025

Enhancing antitumor immunity: the role of immune checkpoint inhibitors, anti-angiogenic therapy, and macrophage reprogramming.

Chong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.